Hematology/Oncology
RSSArticles
-
Pharmacology Watch: Are 5-á Reductase Inhibitors Associated with Hip Fractures?
In the issue: 5-á reductase inhibitors and hip fracture in men; the effects of drug-reimbursement policy on outcomes; new guidelines for type 2 diabetes; beta-blocker-associated brady-cardia is linked to CVD events; FDA Updates. -
Full December 2008 Issue in PDF
-
Special Feature: Tidal Volume Limitation for All Intubated Mechanically Ventilated Patients: Less Is More
The lung-protective effects of low tidal volumes, as demonstrated by the ARDSnet study, are well accepted in patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). -
Is Clot Burden on CT Angiogram Predictive of Mortality in Pulmonary Thromboembolism?
With pulmonary computed tomographic (CT) angiography increasingly used to diagnose acute pulmonary thromboembolism (PE), it has become commonplace to report not only the presence of clot when the study is positive, but also an estimate of the clot burden. -
Clinical Briefs in Primary Care supplement
-
Full November 1, 2008 Issue in PDF
-
Pharmacology Watch
Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions. -
Clinical Briefs in Primary Care Supplement
-
Full November 1, 2008 Issue in PDF
-
Chronic Migraine: Recognition, Prevention, and Treatment
Increased migraine attack frequency and overuse of acute medication, especially barbiturates and opiates, are risk factors for the chronification of migraine, which occurs in up to 2% of individuals.